EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 8th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Executive Employment Agreement (the “Agreement”), made between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Sean Smith (the “Executive” and, collectively with the Company, the “Parties”), is entered into as of August 3, 2022 (the “Effective Date”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 8th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations
This Amendment No. 1 (this “Amendment”), dated as of April 3, 2023, amends that certain Employment Agreement (the “Agreement”), dated as of August 3, 2022, by and between Neoleukin Therapeutics, Inc., a Delaware corporation (the “Company”), and Sean Smith (the “Executive”). All capitalized terms not defined herein shall have the meanings assigned to them in the Agreement.
SEPARATION AGREEMENT AND RELEASESeparation Agreement • May 8th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • Washington
This Separation Agreement and Release (this “Agreement”) is made and entered into by and between Jonathan G. Drachman, MD (“Employee”) and Neoleukin Therapeutics, Inc. (the “Company”). The parties agree as follows:
SEPARATION AGREEMENT AND RELEASESeparation Agreement • May 8th, 2023 • Neoleukin Therapeutics, Inc. • Pharmaceutical preparations • California
This Separation Agreement and Release (this “Agreement”) is made and entered into by and between Priti Patel, M.D. (“Employee”) and Neoleukin Therapeutics, Inc. (the “Company”). The parties agree as follows:
